Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retatrutide is a novel synthetic peptide that acts as a triple receptor agonist targeting GIP (glucose-dependent insulinotropic polypeptide) , GLP-1 (glucagon-like peptide-1) , and glucagon receptors
GLP-1 can cause nausea, which may lead to reduced fluid intake
Your Affinity Medical Provider determines if you qualify for a treatment program, explains treatment options, potential side effects, and answers your medical questions
Their ability to suppress appetite, delay gastric emptying, and enhance insulin sensitivity positions them uniquely to combat the multifaceted drivers of obesity
:max_bytes(150000):strip_icc()/vwh-news-ADHD-meds-with-tums-2715313b7adb4f19af24093d2c498188.png)
In humans it is synthesised by the gene GLP1R , which is present on chromosome 6
US$ 20.88
US$ 29.46
US$ 29.17
US$ 25.27
US$ 25.17
US$ 29.18
US$ 23.94
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 20.24
